| abstract |
The present invention relates to a pharmaceutical composition comprising a compound having a log P of at least 5 and a vehicle, wherein said vehicle comprises (a) a fat component in an amount sufficient to effect lymphatic absorption in the mammal, The fat component is selected from mono-glycerides of long chain fatty acids, tri-glycerides of long chain fatty acids, and mono- and tri-glycerides of long chain fatty acids. |